TAM Receptor Tyrosine Kinase: A Promising Drug Target and Biomarker

Target Name: TAM Receptor tyrosine kinase

NCBI ID: P44931

TAM Receptor tyrosine kinase

Other Name(s): TAM receptor tyrosine kinase | TRTK

TAM Receptor Tyrosine Kinase: A Promising Drug Target and Biomarker

The TAM receptor tyrosine kinase (TAMRK) is a protein that plays a crucial role in cell signaling, particularly in the regulation of cell growth, differentiation, and survival. TAMRK is a non-spinal tyrosine kinase that is expressed in various tissues, including the brain, pancreas, and gastrointestinal tract. It is known to be involved in the regulation of cell proliferation, differentiation, and survival, and is potential drug target and biomarker.

Drug Target Potential

TAMRK is a potential drug target due to its involvement in cell signaling pathways. The TAMRK signaling pathway has been shown to play a role in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. TAMRK has been shown to promote cell proliferation and survival, and is involved in the regulation of cell adhesion, migration, and angiogenesis.

One of the TAMRK signaling pathway's key regulators is the protein p120GTP. p120GTP is a GTPase that is involved in the regulation of TAMRK signaling. GTPase activity of p120GTP has been shown to play a role in the regulation of cell proliferation, differentiation, and survival.

Biomarker Potential

TAMRK is also a potential biomarker for various diseases. The TAMRK signaling pathway has been shown to be involved in the regulation of various biological processes, including cell growth, differentiation, and survival. This makes TAMRK an attractive biomarker for the diagnosis and treatment of various diseases.

One of the diseases that can be associated with TAMRK signaling pathway dysfunction is cancer. TAMRK has been shown to promote the growth and survival of cancer cells, and is involved in the regulation of cell adhesion, migration, and angiogenesis. Therefore, TAMRK can be used as a biomarker for the diagnosis and treatment of cancer.

Another disease that can be associated with TAMRK signaling pathway dysfunction is neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. TAMRK has been shown to promote the growth and survival of neurodegenerate cells, and is involved in the regulation of cell adhesion, migration, and angiogenesis. Therefore, TAMRK can be used as a biomarker for the diagnosis and treatment of neurodegenerative diseases.

TAMRK is also an attractive biomarker for the diagnosis and treatment of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. TAMRK has been shown to promote the growth and survival of immune cells, and is involved in the regulation of cell adhesion, migration, and angiogenesis. Therefore, TAMRK can be used as a biomarker for the diagnosis and treatment of autoimmune diseases.

Conclusion

TAM receptor tyrosine kinase (TAMRK) is a non-spinal tyrosine kinase that is involved in the regulation of cell signaling pathways, including cell growth, differentiation, and survival. TAMRK is a potential drug target due to its involvement in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. It is also a potential biomarker for the diagnosis and treatment of these diseases. Further research is needed to fully understand the role of TAMRK in cell signaling and its potential as a drug target and biomarker.

Protein Name: TAM Receptor Tyrosine Kinase (nonspecified Subtype)

The "TAM Receptor tyrosine kinase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TAM Receptor tyrosine kinase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets